Patent · US Active

Cyclic peptides for the treatment of Graves' disease

US11459375B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

ADVANCECOR GMBH · DE

Inventors

Hans-Peter Holthoff · Martinsried, DE
Martin Ungerer · Martinsried, DE
Julia Fassbender · Martinsried, DE
Zhongmin Li · Pocatello, US

Key dates

Filing date	Feb 28, 2018
Grant date	Oct 4, 2022
Priority date	—
Expiry date	Nov 16, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K39/0008
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a cyclic peptide, its use in the treatment, amelioration or prevention of a disease caused by antibodies targeting the thyrotropin-TSH receptor (TSHR) in the thyroid gland, in particular Graves' disease and orbitopathy, and to pharmaceutical compositions comprising the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.